San Francisco, 20 Dec 2018 - “Stem Cells Market Analysis By Product (Adult Stem Cells, hESC, Induced Pluripotent Stem Cells), By Application (Regenerative Medicine, Drug Discovery), By Technology, By Therapy, And Segment Forecasts, 2018 – 2025" - According to a report published by Grand View Research, Inc.; the global stem cells market is projected to reach around USD 15.63 billion by 2025. Increasing scope in clinical applications can drive the market growth during the forecast period (2014 to 2025). Rising research activities focused on boosting the application scope of stem cells is anticipated to positively influence market expansion in near future. These research activities have opened new avenues in terms of implementation of stem cells in regenerative medicine and disease management.
Technological innovations such as continuous supply of induced Pluripotent Stem Cells (iPSCs) and efforts for regeneration of diseased or dying cells are also expected to accelerate growth of the market. Additionally, funding for R&D from government as well as private organizations is expected to fuel the growth over the forecast period. Cellular therapy is recognized as the next big advancement in healthcare sector. Efforts from organizations to build their cellular therapy portfolio is expected to drive the market.
The worldwide stem cells market can be segmented on the basis of product, application, technology, therapy, and region. Based on product, the market can be categorized into induced pluripotent, adult, human embryonic, and very small embryonic like stem cells. Adult stem cell segment is further divided into neuronal, mesenchymal, hematopoietic, and umbilical cord, among others.
The adult stem cells segment is anticipated to continue leading the market during the forecast period. Factors such as long term renewal property and lesser rejection rate are driving the growth. There are no ethical concerns associated with the use of these cells. This factor is anticipated to bode well for the demand in near future. Also, research activities related to organoid generation and drug screening are considered as crucial factors for the segment growth.
As per application, the market for stem cells can be categorized into regenerative medicine and drug discovery and development. The regenerative medicine segment is further classified into neurology, orthopedics, oncology, hematology, cardiovascular and myocardial infraction, injuries, diabetes, liver disorders, and incontinence, among others.
Regenerative medicine is anticipated to hold a significant market share over the forecast period due to existence of numerous pipeline projects. These medicines can cure traumatic injuries and degenerative diseases. Neurology segment is anticipated to hold major market share in terms of revenue owing to availability of the Food and Drug Administration (FDA) approved products. Oncology segment is expected to grow on account of presence of strong pipeline medicines for cancer therapies.
Based on technology, the stem cells market is classified into cell acquisition, cryopreservation, cell production, and expansion and sub-culture. Cell acquisition is further categorized into bone marrow harvest, umbilical blood cord, and apheresis. The segment is anticipated to occupy the largest market share throughout the forecast period owing to their growing importance in cell harvesting. Development of new cells using bone marrow is quicker therefore, it is the most preferred technology. The cell production segment held substantial market share in the past due to constant technological advancements to meet the ever-increasing demand from clinical applications.
As per therapy, the market is split into autologous and allogeneic stem cell therapy. In terms of revenue, the autologous stem cell therapy segment led the market in 2016 due to high acceptance of these products. Moreover, high compatibility of these cells is anticipated to further propel the uptake over the forecast period.
Geographically, the market can be divided into Europe, North America, Asia Pacific, Latin America, and Middle East and Africa. North America is anticipated to account for a large market share over the forecast period. Increasing R&D activities coupled with funding for advanced cellular therapy is projected to bode well for the regional market expansion. Asia Pacific is projected to showcase momentous growth over the forecast period. Ongoing R&D projects in countries such as Singapore, Australia, and Japan are projected impel the regional expansion.
Enhanced commercialization opportunities are likely to further boost the market growth. Also, updated regulatory framework related to regenerative medicine in Japan is projected to create business opportunities in near future. North America holds the large share of the market. This is credited to extensive R&D efforts and huge funding for advance cellular research in the U.S.
Some of the leading companies operating in the stem cells market include Cellular Engineering Technologies Inc.; BrainStorm Cell Therapeutics; Bioheart Inc.; Advanced Cell Technology Inc.; and PromoCell GmbH.
Grand View Research has segmented the global stem cells market on the basis of product, application, technology, therapy, and region:
Stem Cell Product Outlook (Revenue, USD Billion, 2014 - 2025)
- Adult Stem Cells
- Neuronal Stem Cells
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Umbilical Cord Stem Cells
- Others
- Human Embryonic Stem Cells
- Induced Pluripotent Stem Cells
- Very Small Embryonic Like Stem Cells
Stem Cell Application Outlook (Revenue, USD Billion, 2014 - 2025)
- Regenerative Medicine
- Neurology
- Orthopedics
- Oncology
- Hematology
- Cardiovascular and Myocardial Infraction
- Injuries
- Diabetes
- Liver Disorder
- Incontinence
- Others
- Drug Discovery and Development
Stem Cell Technology Outlook (Revenue, USD Billion, 2014 - 2025)
- Cell Acquisition
- Bone Marrow Harvest
- Umbilical Blood Cord
- Apheresis
- Cell Production
- Therapeutic Cloning
- In-vitro Fertilization
- Cell Culture
- Isolation
- Cryopreservation
- Expansion and Sub-Culture
Stem Cell Therapy Outlook (Revenue, USD Billion, 2014 - 2025)
- Autologous Stem Cell Therapy
- Allogeneic Stem Cell Therapy
Stem Cell Regional Outlook (Revenue, USD Billion, 2014 - 2025)
- North America
- US.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Middle East & Africa
- South Africa
Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-stem-cells-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment